464280 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
TDS Pharm Co. Ltd. engages in the development and manufacture of transdermal drug delivery systems. Its products include cataplasma, plasta, fucidin band, and prescription drugs. The company was founded on November 11, 2002 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
464280 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company